AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $470 | -72.1% | 25,699 | -67.0% | 0.00% | -100.0% |
| Q2 2023 | $1,682 | -30.0% | 77,984 | -4.8% | 0.00% | 0.0% |
| Q1 2023 | $2,404 | +69.1% | 81,906 | +112.8% | 0.00% | 0.0% |
| Q4 2022 | $1,422 | -99.7% | 38,495 | +104.8% | 0.00% | 0.0% |
| Q3 2022 | $529,000 | +4709.1% | 18,800 | +3169.6% | 0.00% | – |
| Q2 2022 | $11,000 | -45.0% | 575 | -63.1% | 0.00% | – |
| Q1 2022 | $20,000 | – | 1,559 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,472,033 | $154,038,000 | 4.47% |
| Ghost Tree Capital, LLC | 550,000 | $15,483,000 | 4.35% |
| Ghost Tree Capital, LLC | 500,000 | $14,075,000 | 3.95% |
| Bain Capital Life Sciences Investors, LLC | 1,023,214 | $28,803,000 | 3.44% |
| Boxer Capital, LLC | 2,084,000 | $58,665,000 | 3.30% |
| Alpha Wave Global, LP | 700,635 | $19,723,000 | 2.33% |
| Soleus Capital Management, L.P. | 429,336 | $12,086,000 | 1.64% |
| Ikarian Capital, LLC | 250,000 | $7,037,000 | 1.40% |
| Cormorant Asset Management, LP | 610,000 | $17,172,000 | 1.20% |
| SECTORAL ASSET MANAGEMENT INC | 205,400 | $5,782,000 | 1.14% |